Chimerix Announces Commencement of Public Offering of Common Stock

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. MRNA
6. SAP
7. CSX
8. LRCX
9. MRK
10. LVS

Go back to Chimerix Announces Commencement of Public Offering of Common Stock

Chimerix (CMRX) Prices 3.78M Offering at $39.75/Share

June 11, 2015 6:53 AM EDT

Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced the pricing of an underwritten public offering of 3,775,000 shares of its common stock at a price to the public of $39.75 per share. The gross... More

Chimerix (CMRX) to Commence $150M Common Stock Offering

June 9, 2015 4:32 PM EDT

Chimerix, Inc. (Nasdaq: CMRX), a biopharmaceutical company developing novel, oral antivirals in areas of high unmet medical need, today announced that it intends to offer and sell, subject to market and other conditions, approximately $150.0 million of its common stock in an underwritten public offering.... More